Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Closed Date6/2013

General Information

Offices

People

CEO
Board of Directors

Funding

TOTAL $3.27M
FUNDING TOTAL $3.27M
Series A, 11/2011
Morgenthaler Ventures
HealthCare Ventures
High Country Venture
$1M
Venture Round, 2/2014
$2.27M

Tags

Mosaic Biosciences Closed down June, 2013

Mosaic Biosciences

Mosaic Biosciences is advancing a fundamentally new class of synthetic materials to support native tissue regeneration. With its proprietary platform technology, Mosaic expects to significantly impact the field of tissue regeneration, including applications in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers.

Mosaic’s products are based on a novel and patented technology platform that can be used to develop synthetic extracellular matrices for support of natural tissue regeneration. These 3-dimensional scaffolds are designed to have the specific biophysical and biochemical properties necessary to support native tissue structures and promote new tissue formation.

Recent Milestones

Videos

Screenshots

Sources

  1. Mosaic Biosciences, Inc.: Series A $1M (onbiovc.com) [edit]
  2. SEC (sec.gov) [edit]
Edit This Page
Last Edited 2/11/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy